Sung, Richard and Holman, Bennett (2022) Against Evidentiary Pluralism in Pharmaceutical Regulation. In: UNSPECIFIED.
|
Text
PSA 2022 Sung and Holman - Against Evidentiary Pluralism in Pharmaceutical Regulation.pdf Download (171kB) | Preview |
Abstract
We examine arguments for and against the use of mechanistic evidence in assessing treatment efficacy and find that advocates of EBM+ and their critics have largely been talking past each other due to difference in focus. We explore aducanumab for the treatment of Alzheimer’s disease as a case which may (eventually) speak to the role of EBM+ in pharmaceutical regulation. The case suggests the debate may be more fruitful if philosophers confine debates to particular domains of medical science and weigh in prospectively instead of relying on historical cases where outcomes are known and which are susceptible to hindsight bias.
Export/Citation: | EndNote | BibTeX | Dublin Core | ASCII/Text Citation (Chicago) | HTML Citation | OpenURL |
Social Networking: |
Item Type: | Conference or Workshop Item (UNSPECIFIED) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Creators: |
|
|||||||||
Keywords: | EBM+, clinical trials, drug regulation, commercialization | |||||||||
Subjects: | General Issues > Evidence Specific Sciences > Medicine General Issues > Social Epistemology of Science General Issues > Values In Science |
|||||||||
Depositing User: | Mr. Richard Sung | |||||||||
Date Deposited: | 12 Jul 2022 03:53 | |||||||||
Last Modified: | 12 Jul 2022 03:53 | |||||||||
Item ID: | 20874 | |||||||||
Subjects: | General Issues > Evidence Specific Sciences > Medicine General Issues > Social Epistemology of Science General Issues > Values In Science |
|||||||||
Date: | 2022 | |||||||||
URI: | https://philsci-archive.pitt.edu/id/eprint/20874 |
Monthly Views for the past 3 years
Monthly Downloads for the past 3 years
Plum Analytics
Actions (login required)
View Item |